ABT Competitors
Abbott Laboratories
$109.93
-$3.67(-3.23%)
66
Overall
90
Value
63
Tech
47
Quality
Market Cap
$190.39B
Volume
8.35M
52W Range
$81.97 - $132.03
Target Price
$118.69
ABT competitors: JNJ, PFE, MDT, TMO, BMY. Abbott Laboratories is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
ABT Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| JNJ Johnson & Johnson | $276.22 | $664.95B | $11.12 | 1.91% | 70 |
| PFE Pfizer Inc. | $29.39 | $167.52B | $3.01 | 4.39% | 76 |
| MDT Medtronic plc | $101.80 | $130.22B | $5.98 | 2.81% | 75 |
| TMO Thermo Fisher Scientific Inc. | $694.76 | $257.42B | $25.28 | 0.26% | 60 |
| BMY Bristol-Myers Squibb Company | $62.14 | $127.02B | $6.43 | 4.06% | 69 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABT | $109.93 | -3.2% | 8.35M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |